Akero Therapeutics ( ($AKRO) ) has released its Q4 earnings. Here is a breakdown of the information Akero Therapeutics presented to its investors.

Synchrony Financial closed 14.45% short of its 52-week high of $70.93, which the company reached on January 23rd.

NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

India at the United Nations called for the reforms of the Security Council, stressing that the demand in this Chamber for ...

Synchrony Financial partners with retailers and medical providers to offer promotional financing as well as private-label and co-branded general-purpose credit cards. While the company’s CareCredit ...

Synchrony (SYF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

Synchrony (SYF) has been beaten down lately with too much selling pressure. While the stock has lost 13.2% over the past four ...

You can now sign up for a credit card at many dentists, doctors and veterinarian offices. These specialty cards can help pay your medical bills, but there are things experts say you need to know ...

Bringing research from the lab to the home, from a controlled environment to real life, can be a way to understand human ...

"I'm angry! I mean, I'm hurt! I live in a little bit of a world where you're not supposed to do that to people,” Liz Johnson ...

Gilead Sciences, Exelixis, Synchrony Financial and Molson Coors have been highlighted in this Screen of The Week article.